APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Thrombin Protein

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Recombinant Human Thrombin Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025192 pages

Choose your research edition.

Industry ResearchRecombinant Human Thrombin Protein Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Thrombin Protein Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Recombinant Human Thrombin Protein Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Thrombin Protein Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Thrombin Protein Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Recombinant Human Thrombin Protein market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Recombinant Human Thrombin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Recombinant Human Thrombin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Human Thrombin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Recombinant Human Thrombin Protein is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Human Thrombin Protein include Takeda, Grifols, Pfizer, Bayer, Shanghai RAAS, Omrix Biopharmaceuticals, Octapharma, Hualan Biological and Haematologic Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Recombinant Human Thrombin Protein market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Recombinant Human Thrombin Protein and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Recombinant Human Thrombin Protein sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Recombinant Human Thrombin Protein market size, projected growth trends, production technologies, key applications, and end-use industries.

Recombinant Human Thrombin Protein Segment by Company

Takeda

Grifols

Pfizer

Bayer

Shanghai RAAS

Omrix Biopharmaceuticals

Octapharma

Hualan Biological

Haematologic Technologies

GE Healthcare

CSL

Recombinant Human Thrombin Protein Segment by Type

Based Bovine

Based Human

Others

Recombinant Human Thrombin Protein Segment by Application

Hospitals

Clinics

Academic and Research Institute

Recombinant Human Thrombin Protein Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Thrombin Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Thrombin Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Thrombin Protein.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Recombinant Human Thrombin Protein market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Human Thrombin Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Recombinant Human Thrombin Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Recombinant Human Thrombin Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Recombinant Human Thrombin Protein Industry Trends Table 2. Recombinant Human Thrombin Protein Industry Drivers Table 3. Recombinant Human Thrombin Protein Industry Opportunities and Challenges Table 4. Recombinant Human Thrombin Protein Industry Restraints Table 5. Global Recombinant Human Thrombin Protein Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Recombinant Human Thrombin Protein Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Recombinant Human Thrombin Protein Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Recombinant Human Thrombin Protein Sales Market Share by Manufacturers Table 9. Global Recombinant Human Thrombin Protein Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Recombinant Human Thrombin Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Recombinant Human Thrombin Protein Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Recombinant Human Thrombin Protein Manufacturers, Product Type & Application Table 13. Global Recombinant Human Thrombin Protein Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Recombinant Human Thrombin Protein by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Based Bovine Table 17. Major Manufacturers of Based Human Table 18. Major Manufacturers of Others Table 19. Global Recombinant Human Thrombin Protein Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Recombinant Human Thrombin Protein Sales by Type (2021-2026) & (K Units) Table 21. Global Recombinant Human Thrombin Protein Sales by Type (2027-2032) & (K Units) Table 22. Global Recombinant Human Thrombin Protein Sales Market Share by Type (2021-2026) Table 23. Global Recombinant Human Thrombin Protein Sales Market Share by Type (2027-2032) Table 24. Global Recombinant Human Thrombin Protein Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Recombinant Human Thrombin Protein Revenue by Type (2021-2026) & (K Units) Table 26. Global Recombinant Human Thrombin Protein Revenue by Type (2027-2032) & (K Units) Table 27. Global Recombinant Human Thrombin Protein Revenue Market Share by Type (2021-2026) Table 28. Global Recombinant Human Thrombin Protein Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospitals Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Academic and Research Institute Table 32. Global Recombinant Human Thrombin Protein Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Recombinant Human Thrombin Protein Sales by Application (2021-2026) & (K Units) Table 34. Global Recombinant Human Thrombin Protein Sales by Application (2027-2032) & (K Units) Table 35. Global Recombinant Human Thrombin Protein Sales Market Share by Application (2021-2026) Table 36. Global Recombinant Human Thrombin Protein Sales Market Share by Application (2027-2032) Table 37. Global Recombinant Human Thrombin Protein Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Recombinant Human Thrombin Protein Revenue by Application (2021-2026) & (K Units) Table 39. Global Recombinant Human Thrombin Protein Revenue by Application (2027-2032) & (K Units) Table 40. Global Recombinant Human Thrombin Protein Revenue Market Share by Application (2021-2026) Table 41. Global Recombinant Human Thrombin Protein Revenue Market Share by Application (2027-2032) Table 42. Global Recombinant Human Thrombin Protein Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Recombinant Human Thrombin Protein Sales by Region (2021-2026) & (K Units) Table 44. Global Recombinant Human Thrombin Protein Sales Market Share by Region (2021-2026) Table 45. Global Recombinant Human Thrombin Protein Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Recombinant Human Thrombin Protein Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Recombinant Human Thrombin Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Recombinant Human Thrombin Protein Sales by Country (2021-2026) & (K Units) Table 49. North America Recombinant Human Thrombin Protein Sales by Country (2027-2032) & (K Units) Table 50. Europe Recombinant Human Thrombin Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Recombinant Human Thrombin Protein Sales by Country (2021-2026) & (K Units) Table 52. Europe Recombinant Human Thrombin Protein Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Recombinant Human Thrombin Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Recombinant Human Thrombin Protein Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Recombinant Human Thrombin Protein Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Recombinant Human Thrombin Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Recombinant Human Thrombin Protein Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Recombinant Human Thrombin Protein Sales by Country (2027-2032) & (K Units) Table 59. Global Recombinant Human Thrombin Protein Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Recombinant Human Thrombin Protein Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Recombinant Human Thrombin Protein Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Recombinant Human Thrombin Protein Revenue Market Share by Region (2021-2026) Table 63. Global Recombinant Human Thrombin Protein Revenue Market Share by Region (2027-2032) Table 64. Takeda Company Information Table 65. Takeda Business Overview Table 66. Takeda Recombinant Human Thrombin Protein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Takeda Recombinant Human Thrombin Protein Product Portfolio Table 68. Takeda Recent Development Table 69. Grifols Company Information Table 70. Grifols Business Overview Table 71. Grifols Recombinant Human Thrombin Protein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Grifols Recombinant Human Thrombin Protein Product Portfolio Table 73. Grifols Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Recombinant Human Thrombin Protein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer Recombinant Human Thrombin Protein Product Portfolio Table 78. Pfizer Recent Development Table 79. Bayer Company Information Table 80. Bayer Business Overview Table 81. Bayer Recombinant Human Thrombin Protein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Bayer Recombinant Human Thrombin Protein Product Portfolio Table 83. Bayer Recent Development Table 84. Shanghai RAAS Company Information Table 85. Shanghai RAAS Business Overview Table 86. Shanghai RAAS Recombinant Human Thrombin Protein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Shanghai RAAS Recombinant Human Thrombin Protein Product Portfolio Table 88. Shanghai RAAS Recent Development Table 89. Omrix Biopharmaceuticals Company Information Table 90. Omrix Biopharmaceuticals Business Overview Table 91. Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Product Portfolio Table 93. Omrix Biopharmaceuticals Recent Development Table 94. Octapharma Company Information Table 95. Octapharma Business Overview Table 96. Octapharma Recombinant Human Thrombin Protein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Octapharma Recombinant Human Thrombin Protein Product Portfolio Table 98. Octapharma Recent Development Table 99. Hualan Biological Company Information Table 100. Hualan Biological Business Overview Table 101. Hualan Biological Recombinant Human Thrombin Protein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Hualan Biological Recombinant Human Thrombin Protein Product Portfolio Table 103. Hualan Biological Recent Development Table 104. Haematologic Technologies Company Information Table 105. Haematologic Technologies Business Overview Table 106. Haematologic Technologies Recombinant Human Thrombin Protein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Haematologic Technologies Recombinant Human Thrombin Protein Product Portfolio Table 108. Haematologic Technologies Recent Development Table 109. GE Healthcare Company Information Table 110. GE Healthcare Business Overview Table 111. GE Healthcare Recombinant Human Thrombin Protein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. GE Healthcare Recombinant Human Thrombin Protein Product Portfolio Table 113. GE Healthcare Recent Development Table 114. CSL Company Information Table 115. CSL Business Overview Table 116. CSL Recombinant Human Thrombin Protein Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. CSL Recombinant Human Thrombin Protein Product Portfolio Table 118. CSL Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Recombinant Human Thrombin Protein Distributors List Table 122. Recombinant Human Thrombin Protein Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Recombinant Human Thrombin Protein Product Image Figure 2. Global Recombinant Human Thrombin Protein Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human Thrombin Protein Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Human Thrombin Protein Sales (2021-2032) & (K Units) Figure 5. Global Recombinant Human Thrombin Protein Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Recombinant Human Thrombin Protein Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Based Bovine Image Figure 9. Based Human Image Figure 10. Others Image Figure 11. Global Recombinant Human Thrombin Protein Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Recombinant Human Thrombin Protein Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Recombinant Human Thrombin Protein Sales Market Share by Type (2021-2032) Figure 14. Global Recombinant Human Thrombin Protein Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Recombinant Human Thrombin Protein Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Recombinant Human Thrombin Protein Revenue Market Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Academic and Research Institute Image Figure 20. Global Recombinant Human Thrombin Protein Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Recombinant Human Thrombin Protein Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Recombinant Human Thrombin Protein Sales Market Share by Application (2021-2032) Figure 23. Global Recombinant Human Thrombin Protein Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Recombinant Human Thrombin Protein Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Recombinant Human Thrombin Protein Revenue Market Share by Application (2021-2032) Figure 26. North America Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Recombinant Human Thrombin Protein Sales Market Share by Country (2021-2032) Figure 28. U.S. Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Recombinant Human Thrombin Protein Sales Market Share by Country (2021-2032) Figure 33. Germany Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Recombinant Human Thrombin Protein Sales Market Share by Country (2021-2032) Figure 40. China Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Recombinant Human Thrombin Protein Sales Market Share by Country (2021-2032) Figure 48. Brazil Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Recombinant Human Thrombin Protein Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Recombinant Human Thrombin Protein Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Recombinant Human Thrombin Protein Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Recombinant Human Thrombin Protein Revenue (2021-2032) & (US$ Million) Figure 59. North America Recombinant Human Thrombin Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Recombinant Human Thrombin Protein Revenue (2021-2032) & (US$ Million) Figure 61. Europe Recombinant Human Thrombin Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Recombinant Human Thrombin Protein Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Recombinant Human Thrombin Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Recombinant Human Thrombin Protein Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Recombinant Human Thrombin Protein Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Recombinant Human Thrombin Protein Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Recombinant Human Thrombin Protein Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Based Bovine
  • Based Human
  • Others
Applications
  • Hospitals
  • Clinics
  • Academic and Research Institute
Companies covered
  • Takeda
  • Grifols
  • Pfizer
  • Bayer
  • Shanghai RAAS
  • Omrix Biopharmaceuticals
  • Octapharma
  • Hualan Biological
  • Haematologic Technologies
  • GE Healthcare
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Recombinant Human Thrombin Protein Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Recombinant Human Thrombin Protein Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Recombinant Human Thrombin Protein Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Recombinant Human Thrombin Protein Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Recombinant Human Thrombin Protein Market Dynamics
  1. 2.1 Recombinant Human Thrombin Protein Industry Trends
  2. 2.2 Recombinant Human Thrombin Protein Industry Drivers
  3. 2.3 Recombinant Human Thrombin Protein Industry Opportunities and Challenges
  4. 2.4 Recombinant Human Thrombin Protein Industry Restraints
3 Recombinant Human Thrombin Protein Market by Manufacturers
  1. 3.1 Global Recombinant Human Thrombin Protein Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Recombinant Human Thrombin Protein Sales by Manufacturers (2021-2026)
  3. 3.3 Global Recombinant Human Thrombin Protein Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Recombinant Human Thrombin Protein Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Human Thrombin Protein Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Recombinant Human Thrombin Protein Manufacturers, Product Type & Application
  7. 3.7 Global Recombinant Human Thrombin Protein Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Human Thrombin Protein Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Human Thrombin Protein Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Human Thrombin Protein Tier 1, Tier 2, and Tier 3
4 Recombinant Human Thrombin Protein Market by Type
  1. 4.1 Recombinant Human Thrombin Protein Type Introduction
  2. 4.1.1 Based Bovine
  3. 4.1.2 Based Human
  4. 4.1.3 Others
  5. 4.2 Global Recombinant Human Thrombin Protein Sales by Type
  6. 4.2.1 Global Recombinant Human Thrombin Protein Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Recombinant Human Thrombin Protein Sales by Type (2021-2032)
  8. 4.2.3 Global Recombinant Human Thrombin Protein Sales Market Share by Type (2021-2032)
  9. 4.3 Global Recombinant Human Thrombin Protein Revenue by Type
  10. 4.3.1 Global Recombinant Human Thrombin Protein Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Recombinant Human Thrombin Protein Revenue by Type (2021-2032)
  12. 4.3.3 Global Recombinant Human Thrombin Protein Revenue Market Share by Type (2021-2032)
5 Recombinant Human Thrombin Protein Market by Application
  1. 5.1 Recombinant Human Thrombin Protein Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Academic and Research Institute
  5. 5.2 Global Recombinant Human Thrombin Protein Sales by Application
  6. 5.2.1 Global Recombinant Human Thrombin Protein Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Human Thrombin Protein Sales by Application (2021-2032)
  8. 5.2.3 Global Recombinant Human Thrombin Protein Sales Market Share by Application (2021-2032)
  9. 5.3 Global Recombinant Human Thrombin Protein Revenue by Application
  10. 5.3.1 Global Recombinant Human Thrombin Protein Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Recombinant Human Thrombin Protein Revenue by Application (2021-2032)
  12. 5.3.3 Global Recombinant Human Thrombin Protein Revenue Market Share by Application (2021-2032)
6 Global Recombinant Human Thrombin Protein Sales by Region
  1. 6.1 Global Recombinant Human Thrombin Protein Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Recombinant Human Thrombin Protein Sales by Region (2021-2032)
  3. 6.2.1 Global Recombinant Human Thrombin Protein Sales by Region (2021-2026)
  4. 6.2.2 Global Recombinant Human Thrombin Protein Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Recombinant Human Thrombin Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Recombinant Human Thrombin Protein Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Recombinant Human Thrombin Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Recombinant Human Thrombin Protein Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Recombinant Human Thrombin Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Recombinant Human Thrombin Protein Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Recombinant Human Thrombin Protein Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Recombinant Human Thrombin Protein Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Recombinant Human Thrombin Protein Revenue by Region
  1. 7.1 Global Recombinant Human Thrombin Protein Revenue by Region
  2. 7.1.1 Global Recombinant Human Thrombin Protein Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Recombinant Human Thrombin Protein Revenue by Region (2021-2026)
  4. 7.1.3 Global Recombinant Human Thrombin Protein Revenue by Region (2027-2032)
  5. 7.1.4 Global Recombinant Human Thrombin Protein Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Recombinant Human Thrombin Protein Revenue (2021-2032)
  8. 7.2.2 North America Recombinant Human Thrombin Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Recombinant Human Thrombin Protein Revenue (2021-2032)
  11. 7.3.2 Europe Recombinant Human Thrombin Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Recombinant Human Thrombin Protein Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Recombinant Human Thrombin Protein Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Recombinant Human Thrombin Protein Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Recombinant Human Thrombin Protein Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Recombinant Human Thrombin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Recombinant Human Thrombin Protein Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Grifols
  8. 8.2.1 Grifols Company Information
  9. 8.2.2 Grifols Business Overview
  10. 8.2.3 Grifols Recombinant Human Thrombin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Grifols Recombinant Human Thrombin Protein Product Portfolio
  12. 8.2.5 Grifols Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Recombinant Human Thrombin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Recombinant Human Thrombin Protein Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Recombinant Human Thrombin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Recombinant Human Thrombin Protein Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Shanghai RAAS
  26. 8.5.1 Shanghai RAAS Company Information
  27. 8.5.2 Shanghai RAAS Business Overview
  28. 8.5.3 Shanghai RAAS Recombinant Human Thrombin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai RAAS Recombinant Human Thrombin Protein Product Portfolio
  30. 8.5.5 Shanghai RAAS Recent Developments
  31. 8.6 Omrix Biopharmaceuticals
  32. 8.6.1 Omrix Biopharmaceuticals Company Information
  33. 8.6.2 Omrix Biopharmaceuticals Business Overview
  34. 8.6.3 Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Omrix Biopharmaceuticals Recombinant Human Thrombin Protein Product Portfolio
  36. 8.6.5 Omrix Biopharmaceuticals Recent Developments
  37. 8.7 Octapharma
  38. 8.7.1 Octapharma Company Information
  39. 8.7.2 Octapharma Business Overview
  40. 8.7.3 Octapharma Recombinant Human Thrombin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Octapharma Recombinant Human Thrombin Protein Product Portfolio
  42. 8.7.5 Octapharma Recent Developments
  43. 8.8 Hualan Biological
  44. 8.8.1 Hualan Biological Company Information
  45. 8.8.2 Hualan Biological Business Overview
  46. 8.8.3 Hualan Biological Recombinant Human Thrombin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hualan Biological Recombinant Human Thrombin Protein Product Portfolio
  48. 8.8.5 Hualan Biological Recent Developments
  49. 8.9 Haematologic Technologies
  50. 8.9.1 Haematologic Technologies Company Information
  51. 8.9.2 Haematologic Technologies Business Overview
  52. 8.9.3 Haematologic Technologies Recombinant Human Thrombin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Haematologic Technologies Recombinant Human Thrombin Protein Product Portfolio
  54. 8.9.5 Haematologic Technologies Recent Developments
  55. 8.10 GE Healthcare
  56. 8.10.1 GE Healthcare Company Information
  57. 8.10.2 GE Healthcare Business Overview
  58. 8.10.3 GE Healthcare Recombinant Human Thrombin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GE Healthcare Recombinant Human Thrombin Protein Product Portfolio
  60. 8.10.5 GE Healthcare Recent Developments
  61. 8.11 CSL
  62. 8.11.1 CSL Company Information
  63. 8.11.2 CSL Business Overview
  64. 8.11.3 CSL Recombinant Human Thrombin Protein Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CSL Recombinant Human Thrombin Protein Product Portfolio
  66. 8.11.5 CSL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Recombinant Human Thrombin Protein Value Chain Analysis
  2. 9.1.1 Recombinant Human Thrombin Protein Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Recombinant Human Thrombin Protein Production Mode & Process
  6. 9.2 Recombinant Human Thrombin Protein Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Recombinant Human Thrombin Protein Distributors
  9. 9.2.3 Recombinant Human Thrombin Protein Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst